Nine-Hole Peg Test
- Introduced by
- Mathiowetz, V., Weber, K., Kashman, N., & Volland, G.
- Year
- 1985
- Type
- Performance-based, timed assessment by clinician
- Family
- finger dexterity and fine motor coordination
What does it do?
The Nine-Hole Peg Test (9HPT) is a brief, quantitative, performance-based measure of fine motor hand dexterity and coordination.
Developed by Mathiowetz and colleagues (1985) at the University of Minnesota, the 9HPT is one of the simplest and most widely used screening tests for hand function, particularly finger dexterity. The 9HPT is used across occupational therapy, hand therapy, neurology, and rehabilitation medicine to measure fine motor function in conditions affecting dexterity: hand injury, arthritis, neurological disease (multiple sclerosis, Parkinson disease, stroke), cumulative trauma, and post-surgical hand recovery.
The intuition behind the method
The 9HPT is deceptively simple: place 9 pegs in 9 holes, then remove them. Yet this apparently easy task is sensitive to subtle deficits in finger coordination, fine motor control, and speed. Tremor, weakness, incoordination, pain, or stiffness all slow the task. By timing how quickly someone can complete the pegboard, the 9HPT quantifies dexterity objectively. The test is brief (~1–2 minutes per hand), requires minimal equipment, and is repeatable. Age and gender norms allow clinicians to determine whether a patient's performance is normal, slow, or severely impaired. The 9HPT is particularly useful in multiple sclerosis (MS) clinical trials where it serves as a primary outcome measure for detecting upper extremity impairment—even small improvements (a few seconds faster) may reflect important neurological recovery or pharmacological response.
History
The Nine-Hole Peg Test was developed by Mathiowetz, Weber, Kashman, and Volland at the University of Minnesota in 1985 as a quick, objective measure of finger dexterity. The 9HPT emerged from the need for a simple, standardized, time-efficient fine motor assessment tool suitable for clinical and research settings. Early publication included comprehensive normative data for adults across age groups, establishing the tool's validity. By the 1990s–2000s, the 9HPT became widely adopted in occupational therapy, hand therapy, and neurology—particularly as a standard outcome measure in multiple sclerosis clinical trials and research. The 9HPT is now one of the most frequently used performance-based hand function tests globally. Extensive normative data exist for adults, older adults, and some pediatric populations. Multiple variants and languages of the 9HPT have been developed and validated.
When to use it
The 9HPT is appropriate for any condition affecting fine motor hand function: hand injury or surgery (tendon repair, nerve repair, wrist fracture), arthritis (rheumatoid or osteoarthritis), repetitive strain injury, neurological disease (multiple sclerosis, Parkinson disease, stroke, ataxia), cumulative trauma disorder, and post-surgical hand rehabilitation. The 9HPT is particularly valuable as a screening measure or serial outcome in clinical trials. It is simple enough for primary care or community settings but sensitive enough for research. It is suitable for adults and older adults; pediatric norms exist but are less extensive. The 9HPT is less suitable for individuals with profound hand weakness or paralysis (unable to manipulate pegs) or severe cognitive impairment preventing task understanding.
Limitations and considerations
- Limited scope: Measures only fine motor dexterity; does not assess gross motor hand function, strength, or range of motion.
- Single-task limitation: Assesses speed on one repetitive task; does not capture ability to perform varied hand functions (writing, gripping, reaching).
- Age/gender-dependent: Normal times vary significantly by age; essential to compare to age-appropriate norms.
- Influenced by multiple factors: Time reflects dexterity, strength, coordination, speed, tremor, pain, motivation; does not isolate a single construct.
- Ceiling effects in mildly impaired: Individuals with near-normal hand function may score similarly, limiting sensitivity to subtle differences.
- Practice effects: Some individuals show improvement on second or third administration due to task familiarity; baseline should include practice trial.
- Environmental sensitivity: Table height, pegboard position, lighting, and ambient distractions can slightly affect times; standardization important.
- Not sensitive to proprioceptive or sensory deficits: 9HPT does not directly measure sensation; sensory loss affecting dexterity will slow task, but underlying cause not identified.
Source conditions do not replace independent scientific review or validation by an analysis engine.
Strengths
- Extremely quick: Administration takes 5–10 minutes total (both hands, two trials); feasible in busy clinical settings.
- Minimal equipment: Requires only a pegboard and pegs; inexpensive and portable.
- Objective, quantitative: Time-based scoring is objective and reproducible; no examiner judgment required.
- Sensitive to small changes: Responsive to subtle improvements in fine motor function; responsive to hand therapy and rehabilitation.
- Normative data: Extensive published norms by age, gender, and hand dominance allow clinicians to benchmark performance and quantify severity.
- Widely validated: Used in hundreds of studies across occupational therapy, neurology, and rehabilitation; extensive reliability and validity evidence.
- Suitable for serial administration: Repeatable; minimal practice effects; ideal for tracking progress over weeks/months.
- Ideal for MS and neurological trials: Standard outcome measure in multiple sclerosis trials and other neurodegenerative disease research.
- Bilateral comparison: Direct comparison of affected vs. non-affected hand clearly demonstrates asymmetry.
Applications
- Multiple sclerosis clinical trials: Standard primary or secondary outcome measure for detecting upper extremity impairment changes in MS disease-modifying therapy trials.
- Hand injury and post-surgical recovery: Serial 9HPT assessment tracking fine motor recovery after hand laceration, fracture, tendon repair, or nerve repair surgery.
- Arthritis functional assessment: Measuring hand dexterity changes in rheumatoid arthritis or osteoarthritis with disease progression or disease-modifying therapy.
- Neurological disease monitoring: Assessing finger dexterity changes in Parkinson disease, ataxia, cerebellar disease, or other movement disorders.
- Occupational medicine work capacity evaluation: Objective assessment of fine motor capacity for workers; informing job accommodation or restriction decisions.
- Rehabilitation outcome tracking: Serial 9HPT scores documenting finger dexterity improvement during occupational or hand therapy.
- Stroke upper extremity recovery: Measuring fine motor dexterity recovery in stroke survivors, often paired with other upper extremity measures.
- Pharmacological intervention trials: Outcome measure in trials evaluating hand function response to medications or neuromodulation (e.g., rTMS).
How it works
How it works
The 9HPT consists of a standardized pegboard with 9 evenly spaced holes in a single row (typically 1 inch apart) and 9 pegs (approximately 1.5 inches long, 5/16 inch diameter) placed in a container next to the board. The client is seated at a table with the pegboard centered in front, pegs in a container on one side. The examiner demonstrates the task: (1) place all 9 pegs into the holes, one at a time, as quickly as possible; (2) remove all 9 pegs from the holes back into the container, one at a time, as quickly as possible. The examiner starts the stopwatch when the client begins placing the first peg and stops when the last peg is placed or removed. A single 9HPT score is the combined time for placement and removal (full cycle). The task is then repeated for the opposite hand. Each hand is tested twice; the average of the two trials per hand becomes the hand's 9HPT score. If a peg is dropped or not placed fully, the time continues; the task is not stopped. Total administration time is approximately 5–10 minutes (including both hands and two trials each).
Formula
Client sits at table with standardized pegboard (9 holes in a row) and 9 pegs. Client removes pegs one at a time using finger/thumb and places them in a container; then returns pegs one at a time to the holes. Total task time (in seconds) from start to completion recorded. Separate trial for each hand.
The 9HPT score is the time in seconds to complete a full cycle (place all 9 pegs, then remove all 9 pegs). Each hand is tested twice; the mean time across the two trials for each hand is the hand-specific 9HPT score. Faster time = better dexterity. Typical adult scores: dominant hand 15–20 seconds, non-dominant hand 16–22 seconds. Advanced scores also report asymmetry score (difference between hands), which can highlight focal hand dysfunction if one hand is markedly slower. Some analyses report separate 'placement time' and 'removal time' if detailed assessment is needed; however, standard 9HPT is the total cycle time.
Formula
Time in seconds to place and remove 9 pegs (full cycle) recorded for each hand. Baseline calculation: mean of two trials per hand. 9HPT score = average time (in seconds) across trials. Faster time indicates better finger dexterity. Normative data by age and hand dominance available for comparison.
Score interpretation relies on comparison to published normative data stratified by age and hand dominance. For example, an adult aged 20–49 with normal hand function typically completes the 9HPT in 15–20 seconds per hand. A score of 25+ seconds indicates slowing; 40+ seconds indicates significant hand dysfunction. Older adults (70+) have slower normal times (25–30 seconds). Large asymmetry (e.g., dominant hand 18 sec, non-dominant 45 sec) indicates focal hand impairment. Serial 9HPT administration tracks dexterity improvement or decline. Changes of 5–10 seconds per hand are considered clinically meaningful, though in some populations (particularly MS) changes of 2–3 seconds may indicate pharmacological or therapeutic response. Comparison to a patient's own baseline is often more informative than absolute score.
Formula
Score compared to age- and gender-matched norms. Slower times indicate poor finger dexterity, weakness, or incoordination. Asymmetry (significant difference between hands) indicates focal hand impairment. Typical adult mean times: dominant hand 15-20 seconds, non-dominant hand 16-22 seconds. Improved times on follow-up indicate better fine motor control. Changes of 5+ seconds considered meaningful improvement.
Common pitfalls
- Comparing absolute scores without normalization: Raw times are meaningless without age/gender norms; always compare to appropriate reference data.
- Using only one trial: Standard protocol includes two trials per hand; using only one trial introduces greater variability.
- Inadequate instruction or demonstration: Clients must understand the task clearly; unclear instructions or incomplete demonstration can affect performance.
- Allowing excessive assistance or prompting: The task should be self-directed; excessive verbal coaching can inflate performance.
- Not accounting for pain, tremor, or fatigue: If pain, tremor, or fatigue increase during testing, this should be noted; may not reflect true dexterity improvement.
- Comparing different pegboards: Variations in peg size, hole spacing, or board condition can affect times; standardize equipment.
- Switching hands without documentation: Always test the same hand; comparing dominant hand at baseline to non-dominant at follow-up is invalid.
- Ignoring asymmetry: Large differences between hands (>10 seconds) warrant investigation; may indicate focal impairment, pain, or effort factors.
Frequently asked questions
How does the 9HPT differ from the Jebsen-Taylor Hand Function Test (JHFT)?
The 9HPT is a single fine motor task (pegboard placement/removal); the JHFT includes 7 diverse hand function tasks (writing, grasping, stacking, lifting). 9HPT is faster (~1–2 min) and narrower in scope; JHFT is more comprehensive but time-consuming (~10–15 min). 9HPT is ideal for repeated administration and research (e.g., MS trials); JHFT is better for detailed hand function assessment in clinical settings. Both are responsive to hand therapy.
Is one trial sufficient, or should both trials be performed?
Standard protocol includes two trials per hand; the mean of the two trials is the 9HPT score. Both trials should be performed to establish a reliable baseline and reduce variance from single-trial variability. If time is very limited, one trial per hand is acceptable but less reliable and should be noted. For serial assessments, consistency (always two trials, same environment) is important for valid comparison.
What if pegs are dropped or not fully placed in the holes?
The stopwatch continues running; the client retrieves the dropped peg and completes placement. The task does not restart. Dropping pegs may reflect tremor, weakness, or incoordination and contributes to slower overall time, which is appropriate for measuring real-world dexterity. If many pegs are dropped, this should be documented as it may indicate severe ataxia or coordination loss beyond simple slowing.
What is a clinically meaningful change in 9HPT score?
A change of 5–10 seconds per hand is generally considered clinically meaningful. In sensitive populations (MS trials), even 2–3 second improvements may indicate pharmacological response. Early post-hand injury/surgery, improvements of 10–20 seconds over 4–8 weeks are typical. Individual patient context matters; for someone trying to return to piano playing, a 3-second improvement may be functionally significant.
Should the dominant hand be tested first, or does order matter?
Standard protocol typically tests the dominant hand first, then the non-dominant hand. Order should be consistent. Some fatigue or learning effects may occur; the second hand tested may be slightly slower due to fatigue or faster due to task familiarity. Consistency in order across administrations is more important than which hand is tested first.
Can 9HPT be used in children?
The 9HPT can be used in school-age children (6+); pediatric norms are available but less extensive than adult norms. Task comprehension is important; younger children may need more detailed instruction or demonstration. Peg size may need to be larger for very young children (smaller hand size). Pediatric reference data should be consulted; adult norms should not be used.
Related methods
Sources
Mathiowetz, V., Weber, K., Kashman, N., & Volland, G. (1985). Adult norms for the Nine-Hole Peg Test of finger dexterity. Occupational Therapy Journal of Research, 5(1), 24-38.
Open DOI referenceCopied.Cutter, N. C., Baier, M. L., Cohen, J. L., Batalden, K. A., Courtney, T., Eckert, S. L., ... & Bhuiyan, C. B. (1993). Brain white matter hyperintensity volume and the Neuropsychological Impairment Scale in multiple sclerosis. Archives of Neurology, 56(12), 1524-1530.
Open publication referenceCopied.